![Frontiers | Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia Frontiers | Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia](https://www.frontiersin.org/files/MyHome%20Article%20Library/1037738/1037738_Thumb_400.jpg)
Frontiers | Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia
GRID Plus - Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting. #drrashidsdrugupdates | Facebook
![Anesthesiology on Twitter: "A 10-mg dose of #amisulpride was safe and more effective than placebo in treating #PONV in patients who failed PONV prophylaxis. #anesthesia #anaesthesia #RandomizedControlledTrial #visualAbstract https://t.co/RgIEPbG7Bq ... Anesthesiology on Twitter: "A 10-mg dose of #amisulpride was safe and more effective than placebo in treating #PONV in patients who failed PONV prophylaxis. #anesthesia #anaesthesia #RandomizedControlledTrial #visualAbstract https://t.co/RgIEPbG7Bq ...](https://pbs.twimg.com/media/DzOyoCIWoAYkXVG.jpg)
Anesthesiology on Twitter: "A 10-mg dose of #amisulpride was safe and more effective than placebo in treating #PONV in patients who failed PONV prophylaxis. #anesthesia #anaesthesia #RandomizedControlledTrial #visualAbstract https://t.co/RgIEPbG7Bq ...
![PDF) Amisulpride ��� dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring | Maxine Patel - Academia.edu PDF) Amisulpride ��� dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring | Maxine Patel - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45997870/mini_magick20190210-1167-fv7iv9.png?1549851248)
PDF) Amisulpride ��� dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring | Maxine Patel - Academia.edu
![PDF] D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. | Semantic Scholar PDF] D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e1c89e82cbd44ce2c3081b80c592d13893844cd8/3-Figure2-1.png)
PDF] D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. | Semantic Scholar
![A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/v78n0720F1.gif)
A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com
![Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study | Semantic Scholar Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c35395def8e4741225b8a1a7d6c9c8e744b243be/5-Table3-1.png)
Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study | Semantic Scholar
![A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/v78n0720T1.gif)
A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease | Psychiatrist.com
![Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial - The Lancet Psychiatry Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial - The Lancet Psychiatry](https://www.thelancet.com/cms/asset/7762d38f-8b7a-4b5c-a44f-5a4bc7cca2a3/gr1.gif)
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial - The Lancet Psychiatry
![Figure 1 from Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. | Semantic Scholar Figure 1 from Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/62b8eb974a903ad13965e406b98ffa7792daea08/3-Figure1-1.png)